-+ 0.00%
-+ 0.00%
-+ 0.00%

KYMERA THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $140 FROM $130

Reuters·10/30/2026 10:44:42

Please log in to view news